Clinical Impact of Rapid Molecular Diagnosis of Bloodstream Infections at an Academic Medical Center in New York City
Matthew S. Simon(NewYork–Presbyterian Hospital), David P. Calfee(Cornell University), Christina L. L. Chai(National University of Singapore), Stephen A. Jenkins(Cornell University), Horatio Holzer(Memorial Sloan Kettering Cancer Center), Naveen Galla(Cornell University), Angela Loo(NewYork–Presbyterian Hospital), Linda M. Gerber(Cornell University), Audrey N. Schuetz(Mayo Clinic), Zhengming Chen(Cornell University), Michael J. Satlin(Cornell University), Harjot Singh(Cornell University), John Dillon(Mayo Clinic)
Cited by 0
Related Papers
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
|Clinical Infectious Diseases|2016|3k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
|Nature Genetics|2009|1.1k
Vitamin C selectively kills <i>KRAS</i> and <i>BRAF</i> mutant colorectal cancer cells by targeting GAPDH
|Science|2015|907
COVID-19 in solid organ transplant recipients: Initial report from the US epicenter
|American Journal of Transplantation|2020|837